$1.370.00%0.00

Vorbörslich: 1.30-0.07 -5.11%

Regentis Biomaterials Ltd. (RGNT)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relatives Volumen:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1Y Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Regentis Biomaterials Ltd. Aktie (RGNT) Unternehmensprofil

Regentis Biomaterials Ltd.

Nächster Verdiensttermin

Neueste SEC-Einreichungen

RGNT-Diskussionen auf X

Finanzdaten der Regentis Biomaterials Ltd.-Aktie (RGNT)

Zeitraum	Trend	FY 2025
Enddatum des Zeitraums		2025-12-31
Operating income USD (M)		-6.97
Income before tax USD (M)		13.65
Net income USD (M)		-13.65
Basic EPS USD/shares		-24.16
Diluted EPS USD/shares		-24.16
Basic weighted shares shares (M)		0.57
Diluted weighted shares shares (M)		0.57

Regentis Biomaterials Ltd. Aktie (RGNT) Neueste Nachrichten

Regentis Biomaterials Ltd. (RGNT)

Regentis Biomaterials Ltd. Aktie (RGNT) Unternehmensprofil

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Finanzdaten der Regentis Biomaterials Ltd.-Aktie (RGNT)

Regentis Biomaterials Ltd. Aktie (RGNT) Neueste Nachrichten

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Regentis Biomaterials Ltd. Estimates – AMEX:RGNT - TradingView

Durability as the New Standard in Cartilage Repair: Why Long-Term Results Are Reshaping Global Orthopedic - Benzinga

Regentis Biomaterials (NYSE American: RGNT) Reports Strong Surgeon Interest in GelrinC at International C - Benzinga

A roughly 10-minute knee procedure crosses a U.S. trial enrollment threshold at Regentis (RGNT). - Stock Titan

Regentis Biomaterials Ltd. (RGNT) Stock Price, News, Quote & History - Yahoo! Finance Canada

A study found a knee implant improved knee scores about 100% more than an earlier repair method after two years. - Stock Titan

Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal - Yahoo Finance

Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City - The Globe and Mail

A knee cartilage implant study is more than 50% enrolled - Stock Titan

Regentis Biomaterials Is Addressing the ‘Short-Term Relief, Long-Term Failure’ Problem in Knee Cartilage - Benzinga

Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care - benzinga.com

Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care - Barchart.com

REGENTIS BIOMATERIALS LTD. SEC Filing (Sep 23, 2026) - Stock Titan

Stray alert from IBN tagged to Regentis Biomaterials withdrawn - marketscreener.com

IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd. - Yahoo Finance

Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair - Yahoo Finance

Regentis Biomaterials (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilag - Benzinga

Regentis Biomaterials Ltd. Research & Ratings | RGNT - Barron's

Regentis Biomaterials Ltd. Stock Grades | RGNT - Barron's

Regentis Biomaterials Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 - marketscreener.com

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update - finance.yahoo.com

Regentis (NYSE American: RGNT) says cash lasts to 2027 but issues going‑concern warning - Stock Titan

Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC - Yahoo Finance

Regentis Biomaterials (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks - USA Today

Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks - Yahoo Finance

Regentis Biomaterials (RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market - Yahoo Finance

Regentis Biomaterials Ltd. Revenue Breakdown – AMEX:RGNT - TradingView

Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - Yahoo Finance

Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - newmediawire.com

Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process - Yahoo Finance

Regentis Biomaterials Ltd Actuals & Estimates (AMEX:RGNT) - TradingView

Why Is Regentis Biomaterials Stock Rising On Wednesday? - Benzinga

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement - Yahoo Finance

Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending - Benzinga

RGNT Stock Erupts As GelrinC European Rollout Plans Ignite Trading - StocksToTrade

Why Did RGNT Stock Surge More Than 850% Today? - Yahoo Finance

Regentis Biomaterials (RGNT) withdraws Form F-1 and halts planned offering - Stock Titan

RGNT Stock Slides After Volatile Spike Draws Trader Focus - timothysykes.com

RGNT Stock Rockets On High-Volume Breakout Volatility - StocksToTrade

Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC - Yahoo Finance

10-minute knee implant shows about 2x pain relief vs microfracture - stocktitan.net

Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones - Yahoo Finance

RGNT - Regentis Biomaterials Ltd Forecast, Target Price - Finviz

Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant - Yahoo Finance

RGNT - Finviz

Regentis Biomaterials (RGNT) Is 'One to Watch' - Yahoo Finance

Regentis Biomaterials (RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair - Yahoo Finance

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering - Yahoo Finance

Ähnlich wie RGNT